275 search results
- Current search:
- Gynaecology and Fertility
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
TitlePublished 18 Jul 2017
Interventions for ovarian protection in women with breast cancer undergoing chemotherapy
Gynaecology and Fertility Group Maria Weterings Title Sunday, July 16, 2017 ... -
UpdatedCochrane EvidencePublished 4 Jul 2017
Cycle regimens for frozen-thawed embryo transfer
Review question: Cochrane review authors investigated different regimens used for preparing the uterus (womb) for transferring frozen-thawed embryos to the uterus in women undergoing assisted reproductive technology (ART) to become pregnant. Background In subfertile women undergoing ART, eggs are collected from the ovaries and fertilised by sperm ... -
NewCochrane EvidencePublished 22 Jun 2017
Interventions for unexplained subfertility: a systematic review and network meta-analysis
Protocol: We aim to assess the comparative effectiveness and/or safety of interventions currently being used to treat couples with unexplained subfertility. -
NewCochrane EvidencePublished 19 Jun 2017
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF/ICSI
Protocol: This review has two objectives. These are: to assess the comparative effectiveness (pregnancy and live birth) and safety (ovarian hyperstimulation syndrome) in women undergoing in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI): of different doses of gonadotropin in women subgrouped by their expected response to stimulation, ... -
NewCochrane EvidencePublished 18 Jun 2017
Antibiotic prophylaxis for elective hysterectomy
Review question Are antibiotics effective and safe for preventing postoperative infection in women undergoing elective (non-urgent) hysterectomy? Background Surgical operation carried out to remove the uterus (hysterectomy) is commonly performed. Most cases are performed as non-urgent (elective) procedures for non-cancerous (benign) conditions affecting ... -
Cochrane EvidencePublished 25 May 2017
Pretreatments in in vitro fertilisation/intra-cytoplasmic sperm injection cycles
Review question The aim of this review was to assess whether pretreatment with a combined oral contraceptive pill (COCP) or with progestogen or oestrogen alone influences pregnancy outcomes in couples with low fertility undergoing assisted reproductive technology (ART) Background In vitro fertilisation (IVF; where an egg is mixed with sperm outside ... -
Cochrane EvidencePublished 24 May 2017
Recombinant luteinizing hormone (rLH) and recombinant follicle-stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
Review question What is the effectiveness and safety of a combination of recombinant luteinizing hormone (rLH) and recombinant follicle-stimulating hormone (rFSH) compared to rFSH alone for ovarian stimulation in women undergoing in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI)? Background In natural ovarian cycles, luteinizing ... -
Cochrane EvidencePublished 23 May 2017
Coasting (withholding gonadotrophins) to prevent ovarian hyperstimulation syndrome
Review question To assess the effect of withholding gonadotrophins (coasting) to prevent ovarian hyperstimulation syndrome in assisted reproduction cycles. Background Ovarian hyperstimulation syndrome (OHSS) is a complication of using hormones to induce ovulation (the release of eggs) in IVF (in vitro fertilization). The hormones can sometimes over ... -
Cochrane EvidencePublished 23 May 2017
Metabolomics for improving pregnancy outcomes
Review question Cochrane researchers reviewed the evidence about the effectiveness of metabolomics as an evaluation tool to improve the rates of ongoing pregnancy, live birth, and miscarriage in women who were undergoing assisted reproductive technology (ART). Background Metabolomics is the scientific study of the chemical 'fingerprints' that biological ... -
Cochrane EvidencePublished 8 May 2017
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
Protocol: To assess the effectiveness and safety of the levonorgestrel intrauterine system (LNG-IUS) for treatment of endometrial hyperplasia (EH) with or without atypia.
